All In MedTech

FDA Clearance Tracker · P110008-S015

coflex® Interlaminar Technology

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 22, 2026

Approved

Time to decision

28 days

Received Apr 24, 2026. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P110008-S015
Device name
coflex® Interlaminar Technology
Applicant location
Merignac Gironde
Received
Apr 24, 2026
Decided
May 22, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P110008

Device type

Device class
Class III

Every decision under product code NQO

FDA's approval statement

As written in FDA's record.

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) supplement, which requested termination of study enrollment and subject follow-up for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P110008. Based upon the information submitted, the PMA supplement is approved.

Source documents

Other decisions for Companion Spine France

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.